Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy Sep 21, 2021
Tim Schlidt of Palo Santo Discusses Why Psychedelics Therapy is the Future of End-of-Life Care Sep 13, 2021
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Exploring Psilocybin Treatments in Underserved Indications Jul 30, 2021
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence Jul 6, 2021
Strong Psychedelic Data In 1H 2021 Sets The Stage For Key Endpoint Results Later This Year Jun 23, 2021
MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs Jun 10, 2021